LCAHA
Modify Date: 2025-09-11 14:54:42
LCAHA structure
|
Common Name | LCAHA | ||
|---|---|---|---|---|
| CAS Number | 117094-40-3 | Molecular Weight | 391.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H41NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LCAHALCAHA (LCA hydroxyamide) is a deubiquitinase USP2a inhibitor with IC50s of 9.7 μM and 3.7μM in Ub-AMC Assay and Di-Ub Assay, respectively. LCAHA destabilizes Cyclin D1 and induces G0/G1 arrest by inhibiting deubiquitinase USP2a[1]. |
| Name | LCAHA |
|---|
| Description | LCAHA (LCA hydroxyamide) is a deubiquitinase USP2a inhibitor with IC50s of 9.7 μM and 3.7μM in Ub-AMC Assay and Di-Ub Assay, respectively. LCAHA destabilizes Cyclin D1 and induces G0/G1 arrest by inhibiting deubiquitinase USP2a[1]. |
|---|---|
| Related Catalog | |
| In Vitro | LCAHA inhibits HCT116wt and HCT116 p53-/- colon cancer cells viability with GI50s of 0.87±0.09 and 0.96±0.29μM, respectively, and the LD50s of 27.8±3.9 and 26.5±0.1μM, respectively[1]. Cell Viability Assay[1] Cell Line: HCT116wt and HCT116 p53-/- colon cancer cells Concentration: 0.01, 0.1, 1, 10, and 100 μM Incubation Time: 6 days Result: The GI50s are 0.87±0.09 and 0.96±0.29 μM for HCT116wt and HCT116 p53-/- colon cancer cells, respectively. |
| References |
| Molecular Formula | C24H41NO3 |
|---|---|
| Molecular Weight | 391.59 |
| InChIKey | WZXAGWREMCSWMF-HVATVPOCSA-N |
| SMILES | CC(CCC(=O)NO)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C |